Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 163 results
Author [ Title(Desc)] Year
Filters: Author is Aplenc, Richard  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Rafiee R, Chauhan L, Alonzo TA, et al. "ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial." Blood Cancer J. 2019;9(6):51.
Marsac ML, Hildenbrand AK, Clawson K, et al. "Acceptability and feasibility of family use of The Cellie Cancer Coping Kit." Support Care Cancer. 2012;20(12):3315-24.
Miller TP, Li Y, Kavcic M, et al. "Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia." J. Clin. Oncol.. 2016.
Oshrine BR, Olsen MN, Heneghan M, et al. "Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor." Cancer Genet. 2014;207(4):153-9.
Chisholm KM, Heerema-McKenney AE, Choi JK, et al. "Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group." Blood Adv. 2020;4(23):6000-6008.
McNerney KO, Oranges K, Seif AE, et al. "Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients." J Pediatr Hematol Oncol. 2022;44(2):e507-e511.
Andolina JR, Wang Y-C, Ji L, et al. "Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience." Bone Marrow Transplant. 2022.
Fisher BT, Kavcic M, Li Y, et al. "Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia." Clin. Infect. Dis.. 2014;58(4):502-8.
Kavcic M, Fisher BT, Torp K, et al. "Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database." Pediatr Blood Cancer. 2013;60(3):508-11.
Sung L, Aplenc R, Alonzo TA, et al. "Association between Prolonged Neutropenia and Reduced Relapse Risk in Pediatric AML: A Report from the Children's Oncology Group." Int. J. Cancer. 2016.
Mangum DSpencer, Meyer JA, Mason CC, et al. "Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia." JAMA Oncol. 2021.
Goodman EK, Reilly AF, Fisher BT, et al. "Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals." JAMA Pediatr. 2014;168(10):925-31.
Vujkovic M, Kershenbaum A, Wray L, et al. "Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952." Leuk Res Rep. 2015;4(2):47-50.
Freedman JL, Desai AV, L Bailey C, et al. "Atypical Chronic Myeloid Leukemia in Two Pediatric Patients." Pediatr Blood Cancer. 2016;63(1):156-9.

Pages